C WorldWide Group
PCVX icon

C WorldWide Group’s Vaxcyte PCVX Stock Holding History

C WorldWide Group’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$11.1M Hold
195,000
– – 0.28% 54
2026
Q2 		$11.3M Hold
195,000
– – 0.27% 51
2026
Q1 		$11.3M Hold
195,000
– – 0.24% 48
2025
Q4 		$9M Hold
195,000
– – 0.16% 63
2025
Q3 		$7.02M Hold
195,000
– – 0.11% 67
2025
Q2 		$6.34M Buy
195,000
+100,000
+105% +$3.28M 0.09% 68
2025
Q1 		$3.59M Buy
+95,000
New +$7.6M 0.04% 72

Other funds holding PCVX

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Arizona State Retirement System
Arizona State Retirement System Phoenix, Arizona $20.3B AUM 36.55% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Virginia Retirement Systems
Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

C WorldWide Group's PCVX Position: Q3 2026 in Review

C WorldWide Group held its Vaxcyte (PCVX) position steady in Q3 2026 at 195,000 shares worth $11.1M. The position accounts for 0.28% of the portfolio, ranked #54.

C WorldWide Group first reported a position in PCVX in Q1 2025 and has held it in 7 quarters since. The position peaked at $11.3M in Q2 2026. 100 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

  • C WorldWide Group held 195,000 shares of Vaxcyte worth $11.1M as of Q3 2026.
  • C WorldWide Group left its Vaxcyte share count unchanged in Q3 2026.
  • Vaxcyte made up 0.28% of C WorldWide Group's portfolio in Q3 2026, its #54 holding.
  • C WorldWide Group first reported a position in Vaxcyte in Q1 2025 and has held it in 7 quarters since.
  • C WorldWide Group's Vaxcyte position peaked at $11.3M in Q2 2026.
  • 100 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on C WorldWide Group's 13F filing for Q3 2026, filed 4 Nov 2026.